Inspire Upper Airway Stimulation System

DEVICE2 trials

Sponsors

Inspire Medical Systems, Inc.

Conditions

Obstructive Sleep Apnea

Phase 3

Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)

CompletedNCT01161420

Inspire Medical Systems, Inc.Obstructive Sleep Apnea

Start: 2010-07-31End: 2017-04-30Updated: 2017-08-25

Unknown Phase

Pediatric Post-Approval Registry

RecruitingNCT04457154

Inspire Medical Systems, Inc.Obstructive Sleep Apnea

Start: 2021-11-30End: 2028-04-30Target: 60Updated: 2025-02-25

Related Papers

Hypoglossal Nerve Stimulation and Hypoxic Burden in Patients With Obstructive Sleep Apnea: A Secondary Analysis of the STAR Trial.

2026-05-21

0720 Effect of Hypoglossal Nerve Stimulation on Hypoxic Burden: Analysis of the STAR Trial

SLEEP2025-05-01

Relation between arousability and outcome of upper airway stimulation in the Stimulation for Apnea Reduction (STAR) Trial.

2021-04-018 citations

Model-based analysis of implanted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea

SLEEP2021-02-2717 citations

Endotypic Mechanisms of Successful Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea

American Journal of Respiratory and Critical Care Medicine2020-09-2496 citations

Upper-Airway Stimulation for Obstructive Sleep Apnea

New England Journal of Medicine2014-01-081191 citations